Kai C. Wollert
机构: Professor, Hannover Medical School
每年引用次数
引用次数
引用: 28,000
H-指数: 87
I10-指数 : 175
出版物: 359
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.
Paul Robach , Stefania Recalcati , Domenico Girelli , Cecilia Gelfi
Blood 113 ( 26) 6707 -6715
67
2009
Serum hepcidin levels and muscle iron proteins in humans injected with low‐ or high‐dose erythropoietin
Paul Robach , Stefania Recalcati , Domenico Girelli , Natascia Campostrini
European Journal of Haematology 91 ( 1) 74 -84
17
2013
Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation
Michiel Rienstra , Xiaoyan Yin , Martin G Larson , João D Fontes
American Heart Journal 167 ( 1) 109 -115.e2
55
2014
Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes
Linda Große-Segerath , Paula Follert , Kristina Behnke , Julia Ettich
Nature Communications 15 ( 1) 1076 -1076
2
2024
Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome: Observations From PROVE IT-TIMI 22
Marc P Bonaca , David A Morrow , Eugene Braunwald , Christopher P Cannon
Arteriosclerosis, Thrombosis, and Vascular Biology 31 ( 1) 203 -210
105
2011
The renin-angiotensin system and experimental heart failure.
Kai C Wollert , Helmut Drexler
Cardiovascular Research 43 ( 4) 838 -849
166
1999
Interference of antihypertrophic molecules and signaling pathways with the Ca2+–calcineurin–NFAT cascade in cardiac myocytes
Beate Fiedler , Kai C Wollert
Cardiovascular Research 63 ( 3) 450 -457
91
2004
Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
Jörn Tongers , Beate Fiedler , Danny König , Tibor Kempf
Cardiovascular Research 63 ( 3) 545 -552
55
2004
Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial
Helmut Drexler , Gerd P Meyer , Kai C Wollert
Nature Clinical Practice Cardiovascular Medicine 3 ( Suppl 1) S65 -S68
58
2006
Synchronization and integration of multiple hypertrophic pathways in the heart
Klaus-Dieter Schlüter , Kai C Wollert
Cardiovascular Research 63 ( 3) 367 -372
17
2004
Cell therapy for acute myocardial infarction: where are we heading?
Kai C Wollert , Helmut Drexler
Nature Clinical Practice Cardiovascular Medicine 1 ( 2) 61 -62
18
2004
Growth hormone and proinflammatory cytokine activation in heart failure. Just a new verse to an old sirens' song?
Kai C Wollert , Helmut Drexler
European Heart Journal 24 ( 24) 2164 -2165
6
2003
Growth-differentiation Factor-15 Promotes Anti-inflammatory Effects And Enhances Survival After Experimental Myocardial Infarction
Tibor Kempf , Christian Widera , Udo Bavendiek , Christian Willenbockel
Circulation 116 ( suppl_16) II_165 -II_165
7
2007
Bone Marrow Cell Therapy After Myocardial Infarction: What have we Learned from the Clinical Trials and Where Are We Going?
Kai C Wollert
Regenerating the Heart: Stem Cells and the Cardiovascular System 111 -129
3
2011
Does cell therapy for myocardial infarction and heart failure work?
Kai C Wollert , Helmut Drexler
Mending the Broken Heart 37 -37
3
2009
Prognostic value of growth-differentiation factor-15 in patients with acute pulmonary embolism
Mareike K Lankeit , Tibor Kempf , Claudia Dellas , Mayumi Cuny
Circulation 116 ( suppl_16) II_502 -II_502
2
2007
Non-invasive tracking of endogenous bone marrow cell recruitment after myocardial infarction in mice
James T Thackeray , Mortimer Korf-Klingebiel , Yong Wang , Olga S Kustikova
Circulation 132 ( suppl_3) A17145 -A17145
1
2015
Cell-Based Therapies and Tissue Engineering in Heart Failure
Kai C Wollert , Kerstin Bethmann , Helmut Drexler
WB Saunders 742 -752
1
2011
Why are we unable to completely control the activation of neurohormonal systems in chronic heart failure-and should we be
Helmut Drexler , Kai C Wollert
Dialog. Card. Med 9 238 -242
1
2004
Response by Wollert to Letter Regarding Article,“Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure”
Kai C Wollert
Circulation 145 ( 11) e770 -e770
2022